Common jobs held by immigrant women, such as house cleaners and nurses, may expose them to dangerous chemicals that could increase their risk of breast cancer, according to a new study led by Silent Spring. The findings shed light on overlooked risks for female workers and why some groups of immigrants experience higher rates of breast cancer after moving to the United States.

Mayo Clinic researchers collaborated on a new study led by Eli Lilly showing that the drug abemaciclib improves survival for people with high-risk, early-stage breast cancer.

One in five women with breast or cervical cancer in low- and middle-income countries (LMICs) are diagnosed at an early stage, compared with more than one in three in high-income countries (HICs), new research suggests. For ovarian cancer, the proportion of women diagnosed with early-stage disease was generally lower than 20% (one in five) worldwide, although the situation remains slightly worse for women in LMICs.

University of Colorado Cancer Center member Matthew Sikora, PhD, is a national leader in research into an understudied subtype of breast cancer that’s on the rise in American women, is often more difficult to detect than other forms of breast cancer, and has sharply lower survival rates several years after diagnosis than the most common type of breast cancer. Sikora’s latest research seeks ways to open up a new treatment option for people with this challenging cancer type, known as lobular breast cancer or invasive lobular carcinoma (ILC), representing about 15% of all breast cancer cases.